Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL S GORBY

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1366446049
CMS profile
198180
Location
TYLER, TX

General Payments · PY2018–2024

$10,621.04

  • Reported across 586 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$281.51

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $281.51 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Abbott Laboratories $44.84 2
Novo Nordisk AS $42.15 2
PFIZER INC. $36.68 2
Lilly USA, LLC $35.05 2
EISAI INC. $32.40 1
Otsuka America Pharmaceutical, Inc. $29.47 1
iRhythm Technologies, Inc. $27.40 1
Mylan Specialty L.P. $19.72 1
Astellas Pharma US Inc $13.80 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,858.65 121
PY2019 $1,820.78 109
PY2020 $1,733.59 93
PY2021 $2,189.09 108
PY2022 $1,485.97 78
PY2023 $1,251.45 64
PY2024 $281.51 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $21.25 05/24/2024 Food and Beverage Undisputed 01/23/2026 1125023327 CMS
Abbott Laboratories $23.59 12/12/2024 Food and Beverage Undisputed 01/23/2026 1125023335 CMS
Astellas Pharma US Inc $13.80 04/30/2024 Food and Beverage Undisputed 01/23/2026 1139331802 CMS
Eisai Inc. $32.40 10/31/2024 Food and Beverage Undisputed 01/23/2026 1110765737 CMS
iRhythm Technologies, Inc. $27.40 12/11/2024 Food and Beverage Undisputed 01/23/2026 1154053237 CMS
Lilly USA, LLC $17.72 01/15/2024 Food and Beverage Undisputed 01/23/2026 1135245484 CMS
Lilly USA, LLC $17.33 01/23/2024 Food and Beverage Undisputed 01/23/2026 1135199899 CMS
Mylan Specialty L.P. $19.72 03/18/2024 Food and Beverage Undisputed 01/23/2026 1147348000 CMS
Novo Nordisk Inc $23.22 05/28/2024 Food and Beverage Undisputed 01/23/2026 1096755506 CMS
Novo Nordisk Inc $18.93 08/07/2024 Food and Beverage Undisputed 01/23/2026 1096805507 CMS
Otsuka America Pharmaceutical, Inc. $29.47 01/10/2024 Food and Beverage Undisputed 01/23/2026 1118899842 CMS
PFIZER INC. $21.90 01/09/2024 Food and Beverage Undisputed 01/23/2026 1130943893 CMS
PFIZER INC. $14.78 07/23/2024 Food and Beverage Undisputed 01/23/2026 1131748748 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.